Edgar Filing: PureSafe Water Systems, Inc.

psws_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-09478

PureSafe Water Systems, Inc.

(Exact name of registrant as specified in its charter)

Delaware		86-0515678
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

160 Dupont Street, Plainview, New York		11803
(Address of principal executive offices)		(Zip Code)

(516) 208-8250

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of August 12, 2012, 366,940,231 shares of the common stock of the registrant were issued and 366,935,831 were outstanding.

PURESAFE WATER SYSTEMS, INC.

INDEX

		Page

Part I. Financial Information			3

Item 1.	Financial Statements.		3

	Condensed Consolidated Balance Sheets as of June 30, 2012 (unaudited) and December 31, 2011		4

	Condensed Consolidated Statements of Operations for the Three and Six months Ended June 30, 2012 and 2011 (unaudited)		5

	Condensed Consolidated Statement of Stockholders’ Deficiency for the Period Ended June 30, 2012 (unaudited)		6

	Condensed Consolidated Statements of Cash Flows for the Six months Ended June 30, 2012 and 2011 (unaudited)		7

	Notes to Unaudited Condensed Consolidated Financial Statements		8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.		18

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.		23

Item 4.	Controls and Procedures.		23

Part II. Other Information

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.		25

Item 6.	Exhibits.		26

Signatures			27

PART I — FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS.

Certain information and footnote disclosures required under accounting principles generally accepted in the United States of America have been condensed or omitted from the following consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission. The following unaudited consolidated financial statements should be read in conjunction with the year-end restated consolidated financial statements and notes thereto included in the Company's Form 10-K for the year ended December 31, 2011.

The results of operations for the three and six months ended June 30, 2012 and 2011 are not necessarily indicative of the results for the entire fiscal year or for any other period.

PureSafe Water Systems Inc. and Subsidiary

Condensed Consolidated Balance Sheets

(Unaudited)

	June 30,			December 31,
	2012			2011
ASSETS
Current Assets:
Cash	$	88,007		$	118,228
Inventories		347,062			468,093
Prepaid expenses and other current assets		52,936			56,674
Total Current Assets		488,005			642,995

Property and equipment, net of accumulated depreciation of $123,372 and $151,710, respectively		90,352			136,718
Patents and trademarks, net of accumulated amortization of $38,864 and $29,608, respectively		61,120			64,172
Other assets		134,107			58,560
TOTAL ASSETS	$	773,584		$	902,445

LIABILITIES AND STOCKHOLDERS' DEFICIENCY
Current Liabilities:
Accounts payable and accrued expenses	$	508,933		$	582,446
Accrued compensation		525,245			402,249
Deferred rent payable		7,050			32,800
Accrued consulting and director fees		144,000			144,000
Customer deposits		401,768			130,000
Convertible notes payable to officer and director (including accrued interest of $105,435 and $83,932 and net of debt discount of $0 and $12,623 respectively)		771,435			743,309
Convertible promissory note (including accrued interest of $130,598 and $83,929 and net of debt discount of $221,920 and $39,923, respectively)		1,467,449			989,006
Promissory notes payable (including accrued interest of $200,374 and $190,521, respectively)		511,367			838,265
Fair value of detachable warrants and conversion option		484,200			515,200
Accrued dividends payable		190,328			190,328
Total Current Liabilities		5,011,775			4,567,603

Long Term Liabilities:
Promissory notes payable, net of current portion		11,464			15,200
Total Long Term Liabilities		11,464			15,200
TOTAL LIABILITIES	$	5,023,239		$	4,582,803


Commitments and Contingencies

Stockholders' Deficiency:
Preferred stock $.001 par value; 10,000,000 shares authorized; 184,144 shares issued and outstanding (liquidation preference $2,863,000 and $2,808,850, as of June 30, 2012 and December 31, 2011, respectively)		184			184
Common stock, $.001 par value; 450,000,000 authorized; 348,707,239 shares issued and 348,702,839 shares outstanding at June 30, 2012; 340,389,004 shares issued and 340,384,604 outstanding at December 31, 2011		348,706			340,388
Additional paid-in capital		39,106,480			38,667,448
Treasury Stock, at cost, 4,400 shares of common stock		(5,768	)		(5,768	)
Subscriptions receivable (including accrued interest of $83,625 and $73,538, respectively)		(420,825	)		(410,738	)
Accumulated deficit		(43,278,432	)		(42,271,872	)
Total Stockholders’ Deficiency		(4,249,655	)		(3,680,358	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$	773,584		$	902,445

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

PureSafe Water Systems Inc. and Subsidiary

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended June 30						Six Months Ended June 30
	2012			2011			2012			2011
Sales	$	--			--		$	265,000		$	--

Cost of Sales		85,659			--			282,718			--

Gross Profit (Loss)		(85,659	)		--			(17,718	)		--

Operating Expenses:

Compensation and related benefits, including stock-based compensation of $50,400 and $103,750 for the three months and $241,900 and $754,825 for the six months ended June 30, 2012 and 2011, respectively		207,534			243,493			564,044			1,031,354

Insurance and medical benefits		20,191			36,969			43,849			36,942

Research and development		22,725			36,661			58,239			83,340

Professional, legal and consulting fees, including stock-based compensation of $0 and $0 for the three months and $4,500 and $0 for the six months ended June 30, 2012 and 2011, respectively		63,512			59,235			110,098			131,713

Marketing, including stock-based compensation of $0 and $0 for the three months and $6,400 and $0 for the six months ended June 30, 2012 and 2011, respectively		6,175			(3,536	)		13,654			89,452

Occupancy		70,210			53,125			139,632			96,693

Loss on abandonment of property		--			--			34,708			--

Other administrative and general		73,978			108,297			135,973			288,393

Total Operating Expenses		464,325			534,244			1,100,197			1,757,887

Loss from Operations		(549,984	)		(534,244	)		(1,117,915	)		(1,757,887	)

Other Income (Expense):

Interest income		5,044			5,044			10,088			10,182

Interest expense, including interest to related parties of $17,729 and $16,393 for the three months and $35,225 and $31,238 for six months ended June 30, 2012 and 2011, respectively		(165,455	)		(128,451	)		(296,633	)		(241,287	)

Change in fair value of derivative liability		153,400			--			397,900			--
Total Other Income (Expense)		(7,011	)		(123,407	)		111,355			(231,105	)

Net Loss		(556,955	)		(657,651	)		(1,006,560	)		(1,988,992	)

Dividend on preferred stock		(27,075	)		(27,075	)		(54,150	)		(54,150	)

Net Loss Attributable to Common Stockholders’		(584,070	)		(684,922	)	$	(1,060,710	)	$	(2,043,299	)

Net Loss Attributable to Common Stockholders Per Share basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average number of shares outstanding		346,412,336			329,989,570			345,762,812			326,751,778

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

PureSafe Water Systems, Inc. and Subsidiary

Condensed Consolidated Statement of Stockholders’ Deficiency

For the Six Months ended June 30, 2012

(Unaudited)

									Additional			Treasury									Total
	Preferred Stock				Common Stock				Paid-In			Stock			Subscription			Accumulated			Stockholders’
	Shares		Amount		Shares		Amount		Capital			At Cost			Receivable			Deficit			Deficiency

BALANCE – January 1, 2012		184,144	$	184		340,389,004	$	340,388	$	38,667,448		$	(5,768	)	$	(410,738	)	$	(42,271,872	)	$	(3,680,358	)

Proceeds from sale of common stock:		--		--		1,000,000		1,000		54,000			--			--			--			55,000

Common stock issued in repayment of debt		--		--		4,831,697		4,831		152,219			--			--			--			157,050

Common stock issued for services		--		--		2,486,538		2,487		157,913			--			--			--			160,400

Reclassification of derivative liability		--		--		--		--		(300	)		--			--			--			(300	)
Amortization of warrants and option over the vesting period for employees and non-employees		--		--		--		--		75,200			--			--			--			75,200
Accrued interest		--		--		--		--		--			--			(10,087	)		--			(10,087	)

Net loss																			(1,006,560	)		(1,006,560	)

BALANCE- June 30, 2012		184,144		184		348,707,239		348,706		39,106,480			(5,768	)		(420,825	)		(43,278,432	)		(4,249,655	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

PureSafe Water Systems Inc. and Subsidiary

Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended June 30,
Cash Flows from Operating Activities:	2012			2011
Net loss	$	(1,006,560	)	$	(1,988,992	)
Adjustments to reconcile net loss to net cash used in operating activities -
Loss on abandonment of property		34,708			--
Depreciation and amortization		11,659			41,412
Amortization of patents and trademarks		3,052			3,052
Interest expense – amortization of deferred financing		2,727			--
Stock based compensation		252,800			754,825
Interest receivable		(10,087	)		(10,032	)
Deferred rent		(25,750	)		--
Accretion of debt discount		180,026			163,596
Change in fair value of warrants and embedded conversion option		(397,900	)		--
Change in assets and liabilities -
Prepaid expenses and other current assets		3,737			1,448
Inventories		121,031			(97,587	)
Customer deposits		271,768			(9,405	)
Other assets		32,375			130,000
Accounts payable, accrued expenses, accrued dividends, accrued compensation, accrued consulting and director fees, customer deposits and other current liabilities		134,557			69,936
Net Cash Used in Operating Activities		(391,857	)		(941,747	)

Cash Flows from Investing Activities:
Patent costs		--			(7,400	)
Net Cash Used in Investing Activities		--			(7,400	)

Cash Flows from Financing Activities:
Proceeds from sale of common stock		55,000			267,000
Proceeds from exercise of warrants		--			86,294
Proceeds from sale of common stock to be issued		--			232,316
Proceeds from convertible promissory note		564,608			100,000
Deferred financing costs		(110,649	)
Proceeds from officers and directors convertible loans		--			225,000
Repayment of officers and directors loans		(6,000	)		(40,000	)
Repayment of notes payable		(141,323	)		(2,811	)
Net Cash Provided by Financing Activities		361,636			867,799

Net decrease in cash		(30,221	)		(81,348	)

Cash at beginning of period		118,228			166,758

Cash at end of period	$	88,007		$	85,410

Supplemental Disclosure of Cash Flow Information:
Cash paid during the year for interest		14,855			17,405

Non-Cash Investing and Financing Activities:


Common stock issued in satisfaction of liabilities		157,050			121,843
Reclassification of equity instrument to derivative liabilities		(300	)		--
Debt discount for beneficial conversion feature and warrants		--			103,132

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

PureSafe Water Systems Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

NOTE 1: DESCRIPTION OF BUSINESS.

PureSafe Water Systems, Inc. (the "Company") is a Delaware corporation engaged in the design, development, manufacturing and sales of the PureSafe™ First Response Water System (the “FRWS”), both within and outside of the United States. The Company's corporate headquarters and factory are located in Plainview, New York.

NOTE 2: BASIS OF PRESENTATION AND ACCOUNTING POLICIES.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, these interim financial statements do not include all of the information and footnotes required for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included.

The operating results for the six month period ended June 30, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. These financial statements should be read in conjunction with the financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission on April 16, 2012.

Use of Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The most significant estimates, among other things, are used in accounting for allowances for deferred income taxes, expected realizable values for long-lived assets (primarily intangible assets and property and equipment), contingencies, as well as the recording and presentation of its common stock. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the consolidated financial statements in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.

Principles of Consolidation

The consolidated financial statements of PureSafe Water Systems, Inc. include accounts of the Company and its wholly-owned subsidiary, PureSafe Manufacturing and Research Corporation. Intercompany transactions and balances are eliminated in consolidation.

Inventories

Inventory amounts are stated at lower of first-in, first-out (“FIFO”) cost or market.

Deferred Financing Costs

Cost incurred in conjunction with the debt financing has been capitalized and will be amortized to interest expense using the straight line method, which approximates the interest rate method over the term of the debt and is included as a component of other assets.

Derivative Liabilities

In connection with the issuance of certain convertible promissory notes, the terms of the convertible notes included an embedded conversion feature; which provided for the settlement of certain convertible promissory notes into shares of common stock at a rate which was determined to be variable. The Company determined that the conversion feature was an embedded derivative instrument pursuant to ASC 815 “Derivatives and Hedging”

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible promissory notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method and conversion options at variable rates are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815. Since, “down-round protection” is not an input into the calculation of the fair value of the conversion option and cannot be considered “indexed to the Company’s own stock” which is a requirement for the scope exception as outlined under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Intrinsic Value Method to be materially the same. Warrants that have been reclassed to derivative liability that did not contain “down-round protection” were valued using the black-scholes model. The Company’s outstanding warrants did not contain any down round protection.

The Black-Scholes option valuation model is used to estimate the fair value of the warrants or options granted. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the warrants or options granted

The principal assumptions used in applying the Black-Scholes model were as follows:

	For the six months ended June 30, 2012
Assumptions:
Risk-free interest rate	1.1% to 0.4%
Expected life	6.1 to 0.26 years
Expected volatility	108%
Dividends	0.0%

Stock-Based Compensation

The Company reports stock-based compensation under Accounting Standard Codification (“ASC”) 718 “Compensation – Stock Compensation”. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.

The Company accounts for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.

The Black-Scholes option valuation model is used to estimate the fair values of options. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the subject options or warrants.

The principal assumptions used in applying the Black-Scholes model were as follows:

	For the six months ended June 30, 2012
Assumptions:
Risk-free interest rate	0.51%
Expected life	3
Expected volatility	108%
Dividends	0.0%

NOTE 3: GOING CONCERN.

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred a net loss of approximately $1,007,000 and $2,000,000 for the six months ended June 30, 2012 and 2011, respectively. The Company has a working capital deficit of approximately $4.5 million and $3.9 million as of June 30, 2012 and December 31, 2011, respectively. The Company continues to incur recurring losses from operations and has an accumulated deficit since inception of approximately $43 million. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

The Company’s plans with respect to these matters include restructuring its existing debt and raising additional capital through future issuances of stock and/or debt. The Company is seeking to raise an additional $5 million in the next twelve months to fund the following activities: to manufacture 27 commercial PureSafe FRWS units within the next twelve months; to expand production capability to meet the expected demand for the FRWS domestically by a combination of expanding the current production facility at 160 Dupont Street, re-engineering and value engineering the FRWS to outsource assembly where appropriate; continue to implement our established marketing program, to establish a sales and marketing network which includes hiring a Vice President of Marketing and Sales Directors to achieve additional sales by the third quarter of 2012.

The extent of these initiatives will be contingent upon the amount of capital raised.

The Company can give no assurance that such financing will be available on terms advantageous to us, or at all. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all of its operational activities. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

NOTE 4: RECENT ACCOUNTING PRONOUNCEMENTS.

Recent accounting pronouncements issued by the FASB and the SEC did not have, or are not believed by management to have, a material impact on the Company's present or future consolidated financial statements.

NOTE 5: INVENTORIES

Inventories consist of the following at June 30, 2012,

Raw materials	$	103,161
Finished Goods		243,901
Total	$	347,062

NOTE 6: NET LOSS PER SHARE OF COMMON STOCK.

Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants, convertible preferred stock and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of 847,461 warrants exercisable at $0.001 issued by the Company. These warrants have been included in computing the basic net loss per share for the six months period ended June 30, 2012.

Total shares issuable upon the exercise of warrants and conversion of preferred stock and convertible promissory notes for the six months ended June 30, 2012 and 2011 were as follows:

	June 30,
	2012		2011
Warrants		29,430,536		27,498,529
Convertible promissory notes		42,435,258		11,535,714
Convertible preferred stock		1,545,760		1,545,760
Total		73,411,554		40,580,003

Fair Value

ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.

ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:

	●	Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
	●	Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.
	●	Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.

Liabilities measured at fair value on a recurring basis at June 30, 2012 are as follows:

	Quoted Prices in Active Markets for Identical Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Balance at June 30, 2012
Embedded conversion feature	$	--	$	--	$	284,100	$	284,100
Warrant liability		--		--		200,100		200,100
Balance at June 30, 2012	$	--	$	--	$	484,200	$	484,200

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The Company’s Level 3 liabilities consist of derivative liabilities associated with convertible debt that contains an indeterminable conversion share price and the tainted warrants as the Company cannot determine if it will have sufficient authorized common stock to settle such arrangements.

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets measured at fair value on a recurring basis using significant unobservable inputs during the three months ended June 30, 2012.

				Conversion
	Warrants			Feature			Total
Balance at - January 1, 2012	$	446,400		$	68,800		$	515,200

Included in stock based compensation		17,200			-			17,200
Change in fair value of derivative liability		(289,200	)		(108,700	)		(397,900	)
Included in liabilities (debt discount)		16,400			333,000			349,400
Included in stockholder's equity		9,300			(9,000	)		300
Transfers in and /or out of Level 3		--			--			--
Balance at - June 30, 2012	$	200,100			284,100		$	484,200

NOTE 7: STOCKHOLDERS' DEFICIENCY.

Debt

During the six months ended June 30, 2012, the Company issued total 4,831,697 shares of common stock upon the requests from a note holder to convert partial principal plus accrued interest totaling $157,051 into the company’s common stock based on the terms set forth in the loan. The conversion rates were from $0.016 to $0.044.

Cash

Through Equity Financing:

During the six months ended June 30, 2012, for gross proceeds of $55,000 the Company sold 1,000,000 shares of common stock and warrants to purchase additional 250,000 shares of common stock at exercise price of $0.06 to $0.072. The warrants have a term of three years.

Services

On January 23, 2012, the Company issued 1,000,000 shares of common stock to the Company’s Chief Executive Officer per grant that was approved by the Company’s Board of directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, the Company recorded $65,000 of stock-based compensation in connection with this issuance.

On January 23, 2012, the Company issued 1,000,000 shares of common stock to the Company’s Chief Financial Officer per grant that was approved by the Company’s Board of directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, the Company recorded $65,000 of stock-based compensation in connection with this issuance.

On January 24, 2012, the Company issued an aggregate 300,000 shares of common stock to multiple employee and contractors per grant that was approved by the Company’s Board of directors on January 11, 2012. The shares were fully vested on the date of the grant and accordingly, Company recorded $19,500 of stock-based compensation in connection with this issuance.

On February 7, 2012, the Company issued 86,538 shares of common stock as part of the retainer fee we paid to a consultant for their services rendered. The Company recorded $4,500 consultant fee in connection with this issuance.

On March 2, 2012, the Company issued 100,000 shares of common stock as part of the consultant fee we paid to a consultant for services rendered. The Company recorded $6,400 marketing fee in connection with this issuance.

NOTE 8 - CONVERTIBLE PROMISSORY NOTES PAYABLE

(a)

During the six months ended June 30, 2012, the Company issued multiple convertible promissory notes for gross proceeds of $501,000. The Company issued the lender for each loan a convertible promissory note bearing interest at rates of 6% to 12% per annum with maturity dates of October 23, 2012 to January 25, 2013. The loans and accrued interest are to be paid on the maturity dates. Each loan is evidenced by the promissory note the Company issued to the lender which contains conversion clauses that allow the lenders the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock. Each of the notes contains variable conversion prices representing discount rates between 5% to 42% of market price.

The Company accounted for the issuance of the convertible promissory notes in accordance with ASC 815 ”Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of these notes are recorded net of a total discount of $192,000. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.

(b)

On June 8, 2012, the Company issued a convertible promissory note for gross proceeds of $50,000. The Company issued the lender a convertible promissory note bearing interest at the rate of 8% per annum. The loan and accrued interest plus any applicable redemption premium are to be paid on October 8, 2012, the maturity date. The note contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at variable conversion prices of 65% multiplied by the market price (representing discount rate of 35%). In addition, the Company issued warrants to the lender to allow lender to purchase 500,000 shares of common stock at an exercise price of 5 cents per share.

The Company accounted for the issuance of the convertible promissory notes in accordance with ASC 815 ”Derivatives and Hedging”. Accordingly, the warrants and the embedded conversion option of the convertible note are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of these notes of $50,000 are recorded net of a discount of $43,400. The debt discount consisted of approximately $16,400 related to the fair value of the warrants and approximately $27,000 related to the fair value of the embedded conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.

(c)

In April, 2012, the Company repaid a promissory note of $47,091 and $2,593 accrued interest through issuing a new convertible note of $54,684 to a lender. The Company did not receive any proceeds from the transaction. The loan was paid by the new lender directly to the original promissory note holder. The Company incurred $5,000 financing cost related to this transaction which was added to the principal of this new convertible promissory note. The new convertible promissory note bears interest rate of 8% per annum and is to be paid with accrued interest on September 15, 2012, the maturity date

The note contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at variable conversion prices of the lesser of a) 80% of the lowest traded price of the Company’s common stock for the ten (10) trading day period immediately preceding the conversion date or b) $0.05.

The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 ”Derivatives and Hedging”. Accordingly, the embedded conversion option of the convertible note is recorded as derivative liabilities at its fair market value and is marked to market through earnings at the end of each reporting period. The $54,684 note is recorded net of a discount of $16,000. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.

(d)

On June 8, 2012, the Company entered into a new note with an investor. The proceeds of the note settled two outstanding promissory notes totaling $150,000 of principal plus $8,057 of accrued interest. The new lender and each original note holder signed a securities transfer agreement in which all privileges and rights in the original notes were transferred to the new lender. In addition to all original privileges and rights, the securities transfer agreements contain conversion clauses that allow the new lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock at variable conversion prices of 65% multiplied by the market price (representing discount rate of 35%).

The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 ”Derivatives and Hedging”. Accordingly, the embedded conversion option of the convertible note is recorded as derivative liabilities at its fair market value and is marked to market through earnings at the end of each reporting period. The notes are recorded net of total discount of $85,000. The debt discount relates to the beneficial conversion feature embedded in the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note.

NOTE 9: RELATED PARTY TRANSACTIONS.

(a)

On January 1, 2012, the Company issued a total of 1,077,585 warrants to purchase common stock to its five directors, including warrants issued to the Chief Executive Officer and Chief Financial Officer, each of which received 215,517 warrants for their first quarter of 2012 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved to replace directors annual compensation of $50,000 with three year warrants payable quarterly. The Company recorded $42,000 stock-based compensation in connection with this issuance.

(b)

As discussed in Note 7, on January 23, 2012, the Company issued 1,000,000 shares of common stock to each of the Company’s Chief Executive Officer and Chief Financial Officer per grants that were approved by the Company’s Board of directors on January 11, 2012. The shares were fully vested on the date of the grants and accordingly, the Company recorded $130,000 of stock-based compensation in connection with this issuance.

(c )

On April 2, 2012, the Company issued a total of 1,302,085 warrants to purchase common stock to its five directors, including warrants issued to the Chief Executive Officer and Chief Financial Officer, each of which received 260,417 warrants for their second quarter of 2012 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved to replace directors annual compensation of $50,000 with three year warrants payable quarterly. The Company recorded $33,200 stock-based compensation in connection with this issuance.

(d)	On June 21, 2012, the Company repaid $6,000 principal to Company’s Chief Executive Officer and Chief Financial Officer for loans payable to them.

NOTE 10: COMMITMENTS AND CONTINGENCIES.

Litigation

The Company is, from time to time, subject to litigation incidental to the conduct of its ongoing business. The Company and its counsel believe that the resolution of these matters will not have a material adverse effect on the financial position of the Company.

Operating Leases

In March 2012 management exercised a Good Guy Clause” in its lease and abandoned the space at 25 Fairchild Avenue. Accordingly the Company recorded a charge of $34,707 for the loss on abandonment of property.

On June 28, 2012, the Company signed a lease renewal agreement to extend our lease at 160 Dupont Street for another three years. The minimum annual lease payments due under this lease are as follows::

Year ending	Amount
2013	$	132,178
2014		136,143
2015		140,227
	$	408,548

All other existing terms remain the same.

NOTE 11: SUBSEQUENT EVENTS.

(a)	On July 2, 2012, the Company issued 4,375,000 shares of common stock to a consultant for the service performed. The Company recorded $175,000 consulting fees in connection with the issuance.

(b)

In July, a customer who made a deposit of $130,000 for a PSWS unit in May of 2011 agreed to use the funds the Company owes them to participate in the Company’s private placement at a price of $0.04 per share. The company issued 4,187,500 shares of common stock on July 3, 2012 in connection with the settlement. In addition, the customer also received 1,046,875 warrants with the right to purchase additional 1,046,875 shares of common stock at an exercise price of 4.8 cents per share. The warrants have a term of three years.

(c)

On July 2, 2012, the Company issued a total of 1,470,588 warrants of common stock to its four directors, including warrants issued to the Chief Executive Officer and Chief Financial Officer, each of which received 367,647 warrants for their 3rd quarter of 2012 director fees. The issuance is part of the annual compensation that was authorized by the Company’s Board of Directors on December 6, 2011, when the Board approved to replace directors annual compensation of $50,000 with three year warrants payable quarterly. The Company recorded $12,400 stock-based compensation in connection with this ssuance.

(d)	On July 27, 2012, the Company issued 187,500 shares of common stock as part of the consulting fees we paid to a consultant for their service rendered. The Company recorded $7,500 consultant fee in connection with this issuance.

(e)

Subsequent to the quarter ended June 30, 2012 and through August 8, 2012, the Company issued a convertible notes for gross proceeds of $32,500. The Company issued the lender a convertible promissory note bearing interest rate 6% per annum with maturity date on April 5, 2013. The loan contains conversion clauses that allow the lender the option to convert the loan amount plus all accrued and unpaid interest due under the note into common stock with conversion price equal to 58% of the Market Price (representing discount rate of 42%).

(f)	Subsequent to the period ended June 30, 2012 and through August 12, 2012, the Company issued a total of 9,482,990 shares of common stock upon receiving the requests from multiple lenders to convert a total of $153,304 loan principal and accrued interest into the Company’s common stock.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Introductory Comment

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our financial statements and related notes contained elsewhere in this Quarterly Report on Form 10-Q, as well as our audited financial statements and related notes contained in our Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2012.

Note Regarding Forward-Looking Statements

This quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent that any statements made in this Form 10-Q contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate” “expect,” “hope,” “intend,” “may,” “plan,” “potential,” “product,” “seek,” “should,” “will,” “would” and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation:

●	our ability to raise capital to finance our research and development and operations, when needed and on terms advantageous to us;

●	our ability to manage growth, profitability and marketability of our products;

●	general economic and business conditions;

●	the effect on our business of recent credit-tightening throughout the United States and the world, especially with respect to federal, state, local and foreign government procurement agencies, as well as quasi-public, charitable and private emergency response organizations;

●	the effect on our business of recently reported losses within the financial, banking and other industries and the effect of such losses on the income and financial condition of our potential clients;

●	the impact of developments and competition within the industries in which we intend to compete

●	adverse results of any legal proceedings;

●	the impact of current, pending or future legislation and regulation on water safety, including, but not limited to, changes in zoning and environmental laws and regulations within our target areas of operations;

●	our ability to maintain and enter into relationships with suppliers, vendors and contractors of acceptable quality of goods and services on terms advantageous to us;

●	the volatility of our operating results and financial condition;

●	our ability to attract and retain qualified senior management personnel; and

●	the other risks and uncertainties detailed in this Form 10-Q and, from time to time, in our other filings with the Securities and Exchange Commission.

Readers of this Report on Form 10-Q should carefully consider such risks, uncertainties and other information, disclosures and discussions which contain cautionary statements identifying important factors that could cause our actual results to differ materially from those provided in forward-looking statements. Readers should not place undue reliance on forward-looking statements contained in this Form 10-Q. We do not undertake any obligation to publicly update or revise any forward-looking statements we may make in this Form 10-Q or elsewhere, whether as a result of new information, future events or otherwise.

General

PureSafe Water Systems, Inc. (herein referred to as the “Company”, “Puresafe”, “we”, “us” or “our”) was incorporated in Delaware in 1987. The manufacture and marketing of water coolers and filters constituted a substantial part of our business from 1993 until the fourth quarter of 2001, at which time such operations were sold and we began concentrating on the further development, manufacturing and marketing of a patented line of water purification systems. Between January 2002 and November 2011, we have generated nominal revenues and was deemed for accounting purposes to be a development stage enterprise.

We have generated our first sale of the FRWS in December of 2011 followed by our second sale in the first quarter of 2012. Accordingly, we are no longer deemed to be a development stage enterprise. We are, however, an early stage commercial enterprise. The accompanying unaudited consolidated financial statements have been prepared assuming our company will continue as a going concern. The PureSafe FRWS is the product line by which we have generated our first significant sales since 2001.

Comparison of Results of Operations for the Three Months Ended June 30, 2012 and 2011

Revenues. We recognized $0 revenues for the three month period ended June 30, 2012 as compared with $0 for the same period in 2011.

Cost of goods sold. Cost of goods sold for the three month period ended June 30, 2012 was $85,659 as compared with $0 for the same period in 2011.

Selling, general and administrative. Selling, general and administrative expenses for the three month period ended June 30, 2012 was $464,325 compared to $534,244 for the same period in 2011, a $69,919 or 13% decrease.

The following is an analysis of some categories that have significant fluctuations between 2012 and 2011. Rent related expenses increased $17,085 or 32% from $53,125 in 2011 to $70,210 in 2012. The 32% increase is primarily due to the rent increase and real estate taxes associated with our 160 Dupont Street facility. Stock-based compensation decreased $53,350 from $103,750 in 2011 to $50,400 in 2012. The $53,350, or 51% decrease in stock-based compensation was due to the fair value of warrants and stock issued being much less in the 2nd quarter of 2012 compared to the same period of 2011.

Research and development. Research and development expenses for the three month periods ended June 30, 2012 were $22,725, compared to $36,661 in 2011, a decrease of $13,936 or 38%. Due to fund restriction, we have curtailed the expenses on research and development. However, we understand the vital importance of research and development for our overall success. We are committed to continue to conduct research and development activities to ensure PureSafe FRWS has the most advanced technology within the water filtration equipment industry.

Interest expense - non-debt discount related incurred in the three month periods ended June 30, 2012 and 2011 was $56,787 and $40,370, a $16,417 or 41% increase. The increase of non-debt discount related interest expense was primarily due to the new loans created in the 2nd quarter of 2012.

Interest expense - debt discount related incurred in the three month periods ended June 30, 2012 and 2011 was $108,668 and $88,081, respectively, a $20,587 or a 23% increase. The principal amount of convertible promissory notes we issued in this quarter was significantly larger as compared with the same period of 2011, and as a result, we incurred significantly more debt discount related interest expense.

Change in fair value of warrants and embedded conversion options. Changes in fair value of warrants and embedded conversion options for three months ended June 30, 2012 and 2011 were $(153,400) and $0, respectively.

The accounting treatment, pursuant to ASC 815 “Derivatives and Hedging”, of derivative financial instruments requires that we record the conversion option and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. As a result of issuing the convertible promissory notes, we were required to reclassify all other non-employee warrants and options as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. We reassess the classification of the instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

Comparison of Results of Operations for the Six Months Ended June 30, 2012 and 2011

Revenues. We recognized $265,000 revenues for the six month period ended June 30, 2012 as compared with $0 for the same period in 2011.

Cost of goods sold. Cost of goods sold for the six month period ended June 30, 2012 was $282,718 as compared with $0 for the same period in 2011.

Gross Profit. Gross profit before selling, general and administrative expenses and other income(loss) for the six month period ended June 30, 2012 was ($17,718) as compared with $0 for the same period in 2011.

Selling, general and administrative. Selling, general and administrative expenses for the six month period ended June 30, 2012 was $1,100,197 compared to $1,757,887 for the same period in 2011, a $657,690 or 37% decrease.

The following is an analysis of some categories that have significant fluctuations between 2012 and 2011. Rent related expenses increased $42,939 or 44% from $96,693 in 2011 to $139,632 in 2012. The 44% increase is primarily due to the rent increase and real estate taxes associated with our 160 Dupont Street facility. Stock-based compensation decreased $512,925 from $754,825 in 2011 to $241,900 in 2012. The 68% decrease in stock-based compensation was due to the fair value of warrants and stock issued in two quarters ended June 2012 being much less compared to the same period of 2011.

Total marketing expenses incurred in six month period ended June 30, 2012 were $13,654, compared to $89,452 in the same period of 2011, a $75,798 or 85% decrease. Due to funding restrictions, we have curtailed the activities on marketing and marketing related expenses in 2012. We understand well designed marketing programs, if implemented, are very important to the Company to achieve much needed sales and market shares. When funds allow, we plan to increase spending in marketing and marketing related programs.

Research and development. Research and development expenses for the six month period ended June 30, 2012 were $58,239, compared to $83,340 in 2011, a decrease of $25,101 or 30%. As discussed in the three month comparison section, due to fund restrictions, we have curtailed the expenses on research and development in 2012. We understand the vital importance of research and development for our overall success and are committed to continue to conduct research and development activities to ensure PureSafe FRWS has the most advanced technology within the water filtration equipment industry.

Loss on disposal of Leasehold Improvement. We moved our headquarters to our 160 Dupont Street facility on March 16, 2012. As a result, we wrote-off $34,707 of leasehold improvement from our books and recorded as loss on disposal of equipment.

Interest expense - non-debt discount related incurred in six month periods ended June 30, 2012 and 2011 was $116,607 and $77,691, respectively. The $38,916 or 50% increase was primarily attributable to interest from the new loans that we obtained during the last quarter of 2011 and first six months of 2012.

Interest expense - debt discount related incurred in six month periods ended June 30, 2012 and 2011 was $180,026 and $163,596, respectively, a $16,430 or 10% increase.

Change in fair value of warrants and embedded conversion options. Changes in fair value of warrants and embedded conversion options for six month ended June 30, 2012 and 2011 were $(397,900) and $0, respectively.

On August 3, 2011, the Company borrowed $125,000 from a private investor and issued to the investor a secured convertible promissory note in the principal amount of $125,000 (the “Note”). The Note bears an interest rate of 8% per annum and is convertible at any time after the maturity date (December 1, 2011) into shares of common stock of the Company at a 30% discount from the current market price (as defined in the Note). Because the conversion clause in the note made the total shares that could be converted from the convertible notes not determinable, we were required to reinstate and reclassify all other non-employee warrants and options and embedded conversion options that were reclassified to equity on December 31, 2010 as derivative liabilities and record them at their fair values on the date we issued this convertible promissory note and record any change in fair value as non-operating, non-cash income or expense for each reporting period at each balance sheet date.

The change in fair value of warrants and embedded conversion options for any period is always primarily the result of the following factors. The first factor is the fair value we recorded as the result of new issuances of warrants and the embedded conversion value. The second factor is the reduction of outstanding options or warrants at the end of each period due to warrant/options exercise or warrants/options expired during the same period. The third factor is the fluctuation of the Company’s stock price.

Liquidity and Capital Resources

As of June 30, 2012, we maintained a cash balance of $88,007 as compared to $85,410 as of the same date in 2011.

Net cash used in the operating activities in the six months ended June 30, 2012, compared to same period of 2011 decreased by $549,890 or 58% from $941,747 to $391,857 and $941,747 respectively. The main factor for the decrease of net cash used in operating activities is that we spent considerable less cash on purchasing inventories in 2012 compared to the same period of 2011.

Net cash used in investing activities in 2012 and 2011 was $0 and $7,400.

In the six months ended June 30, 2012 and 2011, we raised $55,000 and $353,294 through sales of our common stock and warrant exercises, respectively. Funds received in the six month periods ended June 30, 2012 and 2011 from sale of common stock to be issued were $0 and $232,316, respectively. Funds received in the six month periods ended June 30, 2012 and 2011 from convertible promissory notes and promissory notes were $564,608 and $100,000, respectively. We incurred $110,649 in financing costs associated with loans created in the six month period ended June 30, 2012, compared to $0 in the same period of 2011. Funds received from officers’ and directors’ convertible loans for the six month periods ended June 30, 2012 and 2011 were $0 and $225,000, respectively. Cash used to repay notes payable in the six month period ended June 30, 2012 and 2011 were $147,323 and $42,811, respectively. From the above activities, net cash provided by financing activities in the three months ended June 30, 2012 and 2011 were $361,636 and $867,799, respectively.

From all the above activities, net cash used for six month periods ended June 30, 2012 and 2011 was $30,221 and $81,348, respectively.

At June 30, 2012, we had a working capital deficit of approximately $4.5 million. We continue to suffer recurring losses from operations and have an accumulated deficit since inception of approximately $43 million. These conditions raise substantial doubt about our ability to continue as a going concern. Our plans with respect to these matters include restructuring existing debt and raising additional capital through future issuances of stock and/or debt. The Company is seeking to raise an additional $5 million in the next twelve months to fund the following activities: to manufacture 27 commercial PureSafe FRWS units; to expand production capability to meet the expected demand for the FRWS domestically by a combination of expanding the current production facility at 160 Dupont Street, re-engineering and value engineering the FRWS to outsource assembly where appropriate; continue to implement our established marketing program, to establish a sales and marketing network which includes hiring a Vice President of Marketing and Sales Directors to achieve additional sales by the third quarter of 2012.

The extent of these initiatives will be contingent upon the amount of capital raised.

We can give no assurance that such financing will be available on terms advantageous to us, or at all. Should we not be successful in obtaining the necessary financing to fund our operations, we would need to curtail certain or all of our operational activities. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern.

Recent Accounting Pronouncements

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of the statements in accordance with these principles requires that we make estimates, using available data and our judgment, for such things as valuing assets, accruing liabilities and estimating expenses. The following is a list of what we believe are the most critical estimations that we make when preparing our consolidated financial statements.

Stock-Based Compensation

We reports stock-based compensation under ASC 718. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.

We account for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718 and 505, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.

The Black-Scholes option valuation model is used to estimate the fair value of the options or their equivalent granted. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants that have no vesting restrictions and that are fully transferable. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the options granted.

We have issued equity instruments in the past to raise capital and as a means of compensation to employees and for the settlement of debt.

Income taxes

We account for income taxes under guidance provided by ASC 740 “Income Taxes” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.

In accordance with ASC 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as “Interest expense, net” in the consolidated statements of operations. Penalties would be recognized as a component of “General and administrative expenses.”

Our uncertain tax positions are related to tax years that remain subject to examination by relevant tax authorities. We file income tax returns in the United States (federal) and in various state and local jurisdictions. We are no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2007.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

This Item is not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance that information required to be disclosed by us in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Our management identified the following material weaknesses as of June 30, 2012.

Entity Level. We recognize the need to provide leadership and guidance to our employees regarding the maintenance and preparation of financial matters. There is a weakness due to the fact that there are not documented policies and procedures in place for certain procedures. An audit committee has not been established.

Financial Reporting. There needs to be a more structured mechanism for evidence of review in the financial reporting process. The following procedures have been implemented since the beginning of 2009, (a) CFO signs and date all financial documents upon the completion of reviewing such documents, (b) all approval or permission will be evidenced by either email or in writing. No oral approval or permission is allowed, (c) General Journal is recorded only after CFO approves (in writing) such entry and (d) monthly bank reconciliations must complete within 15 days after month ends and reviewed by CFO 5 days after the completion of bank reconciliation.

Confidential Reporting Mechanism. We recognize that we need to provide leadership and guidance to our employees, clients and vendors regarding business ethics and professional conduct. A confidential reporting mechanism must be in place for anonymous reporting of a breach to these ethics that will enable prompt and thorough investigation. In January 2009, we implemented a whistleblower program. A toll-free number, as well as an email address, were posted on the homepage of our website to encourage our employee, contractors, sub-contractors, vendors to report any unethical or illegal behavior they suspect.

The entire staff consists of three officers, one Controller and one receptionist. Therefore, we have relied heavily on entity or management review controls to lessen the issue of segregation of duties. Upon receiving adequate financing the Company plans to increase its controls in these areas by hiring more experienced employees in financial reporting, establishing an audit committee and formally documenting the controls the Company has in place.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The design of any system of controls is also based in part on certain assumptions regarding the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Given these and other inherent limitations of control systems, there is only reasonable assurance that our controls will succeed in achieving their stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the second quarter of our 2012 fiscal year that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

Not applicable

ITEM 1A. RISK FACTORS.

This Item is not applicable to smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The following table sets forth the sales of unregistered securities by the Company in the quarterly period ended June 30, 2012.

Date	Title and Amount(1)	Purchaser	Principal Underwriter	Total Offering Price/ Underwriting Discounts
January 1, 2012	Three-year Warrants to purchase 1,077,585 shares of common stock at an exercise price of $0.058 per share issued for compensation to directors of the Company	Board of directors	NA	$-0-/NA
January 13, 2012	500,000 shares of common stock and three year warrants to purchase 125,000 shares of common stock at exercise price $0.072 through 2011 Private Placement.	Private investor	NA	$0.06 per share/NA
January 23, 2012	1,000,000 shares of common stock issued as compensation.	Chief Executive Officer	NA	$0.065 per share/NA
January 23, 2012	1,000,000 shares of common stock issued as compensation.	Chief Financial Officer	NA	$0.065 per share/NA
January 23, 2012	300,000 shares of common stock issued as compensation.	Corporate employee	NA	$0.065 per share/NA
February 7, 2012	86,538 shares of common stock issued for service.	Consultant	NA	$0.052 per share/NA
February 27, 2012	1,245,020 shares of common stock issued through loan conversion.	Private investor	NA	$0.04428 per share/NA
March 2, 2012	100,000 shares of common stock issued for service.	Consultant	NA	$0.064 per share/NA
March 22, 2012	1,518,265 shares of common stock issued through loan conversion.	Private investor	NA	$0.0336 per share/NA
April 2, 2012	Three-year Warrants to purchase 1,602,085 shares of common stock at an exercise price of $0.048 per share issued for compensation to directors of the Company	Board of directors	NA	$-0-/NA
April 5, 2012	500,000 shares of common stock and three year warrants to purchase 125,000 shares of common stock at exercise price $0.06 through 2011 Private Placement.	Private investor	NA	$0.05 per share/NA
April 4, 2012	818,412 shares of common stock issued through loan conversion.	Private investor	NA	$0.0312 per share/NA
May 8, 2012	312,500 shares of common stock issued through loan conversion.	Private investor	NA	$0.0324 per share/NA
May 31, 2012	937,500 shares of common stock issued through loan conversion.	Private investor	NA	$0.0162 per share/NA
June 4, 2012	Three-year Warrants to purchase 30,000 shares of common stock at an exercise price of $0.043 per share issued for service	Consultant	NA	$-0-/NA
June 7, 2012	Three-year Warrants to purchase 20,000 shares of common stock at an exercise price of $0.043 per share issued for service	Consultant	NA	$-0-/NA

(1) The issuances to executives, employees, lenders, consultants and investors are viewed by the Company as exempt from registration under the Securities Act of 1933, as amended (“Securities Act”), alternatively, as transactions either not involving any public offering, or as exempt under the provisions of Regulation D or Rule 701 promulgated by the SEC under the Securities Act.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None.

ITEM 5. OTHER INFORMATION.

On May 4, 2012, Malcolm Hoenlein resigned as a director of the Company for personal reasons. In his resignation letter, Mr. Hoenlein offered to continue to serve as Chairman of the Company’s Advisory Board (in formation) and indicated his intention to continue to work with the Company.

ITEM 6. EXHIBITS.

The following exhibits are being filed as part of this Quarterly Report on Form 10-Q.

Exhibit Number		Description
31.1*		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
32.1**		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Oxley Act of 2002.
32.2**		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Oxley Act of 2002.

* Filed herewith

** Furnished herewith

Copies of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K.

SEC Ref. No.		Title of Document
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Label Linkbase Document
101.PRE		XBRL Taxonomy Presentation Linkbase Document

The XBRL related information in Exhibits 101 to this Quarterly Report on Form 10-Q shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and is not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of those sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	PureSafe Water Systems, Inc.

Dated: August 20, 2012	By:	/s/ Leslie J. Kessler
		Leslie J. Kessler
		Chief Executive Officer

	By:	/s/ Terry R. Lazar
		Terry R. Lazar
		Chief Financial Officer